AbstractPurposeTo elaborate a prediction model for quality of life of cervical cancer survivors.MethodsWe conducted a prospective cohort study on 229 cervical cancer survivors. The quality of life measures included the Functional Assessment Cancer Therapy‐Cervix version 4.0 and the World Health Organization Quality of Life‐brief version self‐administered questionnaires. We imported the data into the statistical software program R and developed a gamma generalized linear model.ResultsOur internally validated predictive model for the Functional Assessment Cancer Therapy‐Cervix total score was composed of the following predictors: pain, appetite, vaginal bleeding/discharge/odor, and WHOQOL‐BREF social relationships domain. The Harrell's concordance index was 0.75.ConclusionsWe developed a solid and internally validated predictive model in cervical cancer survivors based on predictors, such as pain, appetite, vaginal bleeding/odor/discharge, and WHOQOL‐BREF social relationships subscale score that contribute significantly to quality of life as targets for potential intervention.

More from our Archive

• DOI: 10.1002/uog.26309 2023

  Effect of intrapartum epidural analgesia on rate of emergency delivery for presumed fetal compromise: nationwide registry‐based cohort study

  S. E. Damhuis, H. Groen, B. Thilaganathan, W. Ganzevoort, S. J. Gordijn

• DOI: 10.1002/uog.26308 2023

  Epidural analgesia and emergency delivery for presumed fetal compromise: <i>post‐hoc</i> analysis of <scp>RAVEL</scp> multicenter randomized controlled trial

  E. S. E. Tabernée Heijtmeijer, H. Groen, S. E. Damhuis, L. M. Freeman, J. M. Middeldorp, W. Ganzevoort, S. J. Gordijn

• DOI: 10.1111/mcn.13546 2023

  A qualitative study of public health nurses' perspectives and experiences on nutritional guidance for parents of infants and toddlers

  Christine Helle, Elisabet R. Hillesund, Nina Cecilie Øverby

• DOI: 10.1002/uog.26303 2023

  Screening for pre‐eclampsia by maternal serum glycosylated fibronectin at 11−13 weeks' gestation

  N. Sokratous, M. Bednorz, P. Sarli, O. E. Morillo Montes, A. Syngelaki, A. Wright, K. H. Nicolaides

• DOI: 10.1097/ogx.0000000000001159 2023

  Cannabis and Pregnancy: A Review

  Sarena Hayer, Ava D. Mandelbaum, Lester Watch, Kimberly S. Ryan, Madeline A. Hedges, Jennifer A. Manuzak, Charles A. Easley, Danny J. Schust, Jamie O. Lo

• DOI: 10.1002/ijgo.14989 2023

  Descriptive spectrum of thiamine deficiency in pregnancy: A potentially preventable condition

  Sobia Nisar, Ozaifa Kareem, Umar Muzaffer, Masood Tanvir, Mohd. Ashraf Ganaie, Rabia Nazir Ahmed

• DOI: 10.1111/aogs.14602 2023

  Association between levothyroxine treatment for maternal subclinical hypothyroidism with negative <scp>TPOAb</scp> and early child neurodevelopment: A prospective real‐world clinical trial

  Zhekun Zhao, Qiongjie Zhou, Huanqiang Zhao, Yu Xiong, Xiaotian Li

• DOI: 10.1111/jog.15743 2023

  Development and internal validation of a multivariable prediction model for the quality of life of cervical cancer survivors

  Jorge Cea García, Laura Ríos‐Pena, M. Carmen Rubio Rodríguez, Francisco Márquez Maraver, Inmaculada Rodríguez Jiménez

• DOI: 10.1111/ajo.13719 2023

  Intrahepatic cholestasis of pregnancy – Diagnosis and management: A consensus statement of the Society of Obstetric Medicine of Australia and New Zealand (<scp>SOMANZ</scp>): Executive summary

  William M. Hague, Annette Briley, Leonie Callaway, Marloes Dekker Nitert, Jessica Gehlert, Dorothy Graham, Luke Grzeskowiak, Angela Makris, Corey Markus, Philippa Middleton, Michael J. Peek, Antonia Shand, Michael Stark, Jason Waugh

• DOI: 10.1002/ijgo.14983 2023

  Feasibility of 5‐fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (<scp>CIN</scp>) 2/3

  Nerlyne Desravines, Chiu‐Hsieh Hsu, Sopan Mohnot, Vikrant Sahasrabuddhe, Margaret House, Edward Sauter, Siobhan O'Connor, Julie E. Bauman, H.‐H. Sherry Chow, Lisa Rahangdale